Overview
Matthew Harmelink is a Neuromusculoskeletal Medicine provider practicing medicine in Milwaukee, Wisconsin.
His clinical expertise encompasses Neurofibromatosis Type 1 (NF1).
He is actively involved in clinical research, co-authoring 16 peer reviewed articles and participating in 6 clinical trials. Dr. Harmelink is currently accepting new patients.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
Locations
9000 W Wisconsin Ave, Milwaukee, WI 53226
Additional Areas of Focus
Dr. Harmelink has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
6 Clinical Trials
Froedtert Hospital
Dominic Fee is a Neurologist and a Neuromusculoskeletal Medicine provider practicing medicine in Milwaukee, Wisconsin. Dr. Fee is highly rated in 53 conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, and Spinal Muscular Atrophy (SMA). Dr. Fee is board certified in Neurology, Electrodiagnostic Medicine, Clinical Neurophysiology, and Neuromuscular Medicine. Dr. Fee is currently accepting new patients.
Neuroscience Center – Specialty Clinics
David Shirilla is a Neurologist and a Neuromusculoskeletal Medicine provider practicing medicine in Milwaukee, Wisconsin. Dr. Shirilla is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Spinal Muscular Atrophy (SMA), Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease). Dr. Shirilla is board certified in Neurology, Clinical Neurophysiology, and Neuromuscular Medicine. Dr. Shirilla is currently accepting new patients.
Endeavor Health Medical Group
Richard Wlodarski, MD, a neurologist at Endeavor Health, specializes in neuromuscular medicine and cares for patients with myopathies, neuropathies and conditions like myasthenia gravis. He combines curiosity with evidence-based practice to offer patients clarity and treatment options tailored to their condition. Dr. Wlodarski is especially interested in advancing care through new, targeted therapies and disease-modifying treatments for previously untreatable neurological disorders. Dr. Wlodarski is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Peripheral Neuropathy, Orthostatic Hypotension, Familial Dysautonomia, and Low Blood Pressure. Dr. Wlodarski is board certified in American Board Of Psychiatry And Neurology. Dr. Wlodarski is currently accepting new patients.
Frequently Asked Questions about Dr. Matthew M. Harmelink
How do I make an appointment with Dr. Matthew M. Harmelink?
You can book an appointment with Dr. Matthew M. Harmelink by calling their office at 414-266-3464. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
What conditions does Dr. Matthew M. Harmelink specialize in?
While Dr. Matthew M. Harmelink is a Neuromusculoskeletal Medicine, they have specific expertise in Neurofibromatosis Type 1 (NF1). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neuromusculoskeletal Medicine.
Does Dr. Matthew M. Harmelink participate in research or clinical trials?
Yes. Dr. Matthew M. Harmelink has published 16 articles and abstracts on conditions like Neurofibromatosis Type 1 (NF1). You can view a list of Dr. Matthew M. Harmelink's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Matthew M. Harmelink accept my insurance?
Dr. Matthew M. Harmelink accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 414-266-3464 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers


